"cancer pathways" trang 10 - tải miễn phí từ tailieunhanh
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome

A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome
22    9    1
CTCF maintains regulatory homeostasis of cancer pathways

CTCF maintains regulatory homeostasis of cancer pathways
17    18    1
Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways

Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways
13    13    1
Integrated analysis reveals the dysfunction of signalling pathways in uveal melanoma

Integrated analysis reveals the dysfunction of signalling pathways in uveal melanoma
13    17    1
Systematic analysis of histone acetylation regulators across human cancers

Systematic analysis of histone acetylation regulators across human cancers
14    1    1
IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
11    1    1
Ebook Molecular genetics of endometrial carcinoma

Ebook Molecular genetics of endometrial carcinoma
284    3    1
ONCOGENE AND CANCER – FROM BENCH TO CLINIC

ONCOGENE AND CANCER – FROM BENCH TO CLINIC
496    77    0
Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model

Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
10    108    0
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer

A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer
13    31    1
High-throughput sequencing of circRNAs reveals novel insights into mechanisms of nigericin in pancreatic cancer

High-throughput sequencing of circRNAs reveals novel insights into mechanisms of nigericin in pancreatic cancer
11    36    1
Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation

Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation
20    50    1
The transcriptome landscape of the carcinogenic treatment response in the blind mole rat: Insights into cancer resistance mechanisms

The transcriptome landscape of the carcinogenic treatment response in the blind mole rat: Insights into cancer resistance mechanisms
15    29    1
Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis

Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis
14    12    1
Molecular Biology of Human Cancers

Molecular Biology of Human Cancers
529    61    0
Using proteomic profiling to characterize protein signatures of different thymoma subtypes

Using proteomic profiling to characterize protein signatures of different thymoma subtypes
8    95    0
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma

Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
9    55    1
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin

Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
14    47    1
PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models

PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models
10    34    1
Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia

Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia
11    34    1